Image pharmaphorum Editor Healthcare How medical device sales teams can embrace digital transform... Selling amid a global pandemic has changed the face of sales forever. M&A How to get acquisition ready – a seller’s guide to merger an... This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves. Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet. Load more results
Healthcare How medical device sales teams can embrace digital transform... Selling amid a global pandemic has changed the face of sales forever.
M&A How to get acquisition ready – a seller’s guide to merger an... This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.
Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.
Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
